279 related articles for article (PubMed ID: 34587481)
41. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
Front Immunol; 2020; 11():1748. PubMed ID: 32849623
[TBL] [Abstract][Full Text] [Related]
42. Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients.
Lage SL; Rocco JM; Laidlaw E; Rupert A; Galindo F; Kellogg A; Kumar P; Poon R; Wortmann GW; Lisco A; Manion M; Sereti I
Front Immunol; 2022; 13():815833. PubMed ID: 35250994
[TBL] [Abstract][Full Text] [Related]
43. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
44. Proinflammatory IgG Fc structures in patients with severe COVID-19.
Chakraborty S; Gonzalez J; Edwards K; Mallajosyula V; Buzzanco AS; Sherwood R; Buffone C; Kathale N; Providenza S; Xie MM; Andrews JR; Blish CA; Singh U; Dugan H; Wilson PC; Pham TD; Boyd SD; Nadeau KC; Pinsky BA; Zhang S; Memoli MJ; Taubenberger JK; Morales T; Schapiro JM; Tan GS; Jagannathan P; Wang TT
Nat Immunol; 2021 Jan; 22(1):67-73. PubMed ID: 33169014
[TBL] [Abstract][Full Text] [Related]
45. Complement activation in patients with COVID-19: A novel therapeutic target.
Cugno M; Meroni PL; Gualtierotti R; Griffini S; Grovetti E; Torri A; Panigada M; Aliberti S; Blasi F; Tedesco F; Peyvandi F
J Allergy Clin Immunol; 2020 Jul; 146(1):215-217. PubMed ID: 32417135
[No Abstract] [Full Text] [Related]
46. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
Boussier J; Yatim N; Marchal A; Hadjadj J; Charbit B; El Sissy C; Carlier N; Pène F; Mouthon L; Tharaux PL; Bergeron A; Smadja DM; Rieux-Laucat F; Duffy D; Kernéis S; Frémeaux-Bacchi V; Terrier B
J Allergy Clin Immunol; 2022 Feb; 149(2):550-556.e2. PubMed ID: 34800432
[TBL] [Abstract][Full Text] [Related]
47. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
[TBL] [Abstract][Full Text] [Related]
48. Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology.
Ghebrehiwet B; Peerschke EI
J Clin Invest; 2020 Nov; 130(11):5674-5676. PubMed ID: 32925166
[TBL] [Abstract][Full Text] [Related]
49. Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models.
Li D; Luan N; Li J; Zhao H; Zhang Y; Long R; Jiang G; Fan S; Xu X; Cao H; Wang Y; Liao Y; Wang L; Liu L; Liu C; Li Q
Emerg Microbes Infect; 2021 Dec; 10(1):2194-2198. PubMed ID: 34736354
[TBL] [Abstract][Full Text] [Related]
50. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
[TBL] [Abstract][Full Text] [Related]
51. Obesity Correlates With Pronounced Aberrant Innate Immune Responses in Hospitalized Aged COVID-19 Patients.
Zulu MZ; Sureshchandra S; Pinski AN; Doratt B; Shen W; Messaoudi I
Front Immunol; 2021; 12():760288. PubMed ID: 34707619
[TBL] [Abstract][Full Text] [Related]
52. Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
Georg P; Astaburuaga-García R; Bonaguro L; Brumhard S; Michalick L; Lippert LJ; Kostevc T; Gäbel C; Schneider M; Streitz M; Demichev V; Gemünd I; Barone M; Tober-Lau P; Helbig ET; Hillus D; Petrov L; Stein J; Dey HP; Paclik D; Iwert C; Mülleder M; Aulakh SK; Djudjaj S; Bülow RD; Mei HE; Schulz AR; Thiel A; Hippenstiel S; Saliba AE; Eils R; Lehmann I; Mall MA; Stricker S; Röhmel J; Corman VM; Beule D; Wyler E; Landthaler M; Obermayer B; von Stillfried S; Boor P; Demir M; Wesselmann H; Suttorp N; Uhrig A; Müller-Redetzky H; Nattermann J; Kuebler WM; Meisel C; Ralser M; Schultze JL; Aschenbrenner AC; Thibeault C; Kurth F; Sander LE; Blüthgen N; Sawitzki B;
Cell; 2022 Feb; 185(3):493-512.e25. PubMed ID: 35032429
[TBL] [Abstract][Full Text] [Related]
53. The immunology and immunopathology of COVID-19.
Merad M; Blish CA; Sallusto F; Iwasaki A
Science; 2022 Mar; 375(6585):1122-1127. PubMed ID: 35271343
[TBL] [Abstract][Full Text] [Related]
54. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19.
Chilunda V; Martinez-Aguado P; Xia LC; Cheney L; Murphy A; Veksler V; Ruiz V; Calderon TM; Berman JW
Front Immunol; 2021; 12():665773. PubMed ID: 34108966
[TBL] [Abstract][Full Text] [Related]
55. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.
Peerschke EI; Valentino A; So RJ; Shulman S; Ravinder
Front Immunol; 2021; 12():716361. PubMed ID: 34491250
[TBL] [Abstract][Full Text] [Related]
56. An update: the emerging evidence of complement involvement in COVID-19.
Li Q; Chen Z
Med Microbiol Immunol; 2021 Jun; 210(2-3):101-109. PubMed ID: 33811541
[TBL] [Abstract][Full Text] [Related]
57. SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems.
Savitt AG; Manimala S; White T; Fandaros M; Yin W; Duan H; Xu X; Geisbrecht BV; Rubenstein DA; Kaplan AP; Peerschke EI; Ghebrehiwet B
Front Immunol; 2021; 12():767347. PubMed ID: 34804054
[TBL] [Abstract][Full Text] [Related]
58. A scoping review of the pathophysiology of COVID-19.
Marik PE; Iglesias J; Varon J; Kory P
Int J Immunopathol Pharmacol; 2021; 35():20587384211048026. PubMed ID: 34569339
[TBL] [Abstract][Full Text] [Related]
59. Comparisons of the immunological landscape of COVID-19 patients based on sex and disease severity by multi-omics analysis.
Zhang T; Abdelrahman Z; Liu Q; Wang X; Chen Z
Chem Biol Interact; 2022 Jan; 352():109777. PubMed ID: 34896122
[TBL] [Abstract][Full Text] [Related]
60. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury.
Malaquias MAS; Gadotti AC; Motta-Junior JDS; Martins APC; Azevedo MLV; Benevides APK; Cézar-Neto P; Panini do Carmo LA; Zeni RC; Raboni SM; Fonseca AS; Machado-Souza C; Moreno-Amaral AN; de Noronha L
Transl Res; 2021 May; 231():55-63. PubMed ID: 33221483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
